title: [Modern therapy of mycosis fungoides].
abstract: Mycosis fungoides (MF) treatment must be chosen only after staging extent of lymphoma. Stage I and II diseases respond best to either topical nitrogen mustard, photochemotherapy (PUVA), or electron beam. Chemotherapy of stage III and IV MF has only limited remission rates. Combinations of therapies and experimental approaches, such as monoclonal antibodies, may give longer survivals.
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D009182:Mycosis Fungoides / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011701:PUVA Therapy; D011879:Radiotherapy Dosage; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D005446:Fluocinolone Acetonide; D008466:Mechlorethamine
vernacular_title: Moderne Therapie der Mycosis fungoides.